How virtual and mixed reality are changing drug delivery and device design

Kai Worrell believes that virtual and mixed reality may change the way companies design medical devices, and he’s putting that idea into practice.

“We think it’s going to transform the way we do feasibility testing and cognitive walk-through simulations,” he said. “We think it’s going to help us understand the cognition of our users, clinical and the families that we’re serving.”

When a pharmaceutical company approached his design firm, Worrell, about a product for patients with multiple sclerosis, the company used virtual reality to get a deeper understanding of what it’s like to live with the physically debilitating disease.

Get the full story at our sister site, Drug Delivery Business News.

[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW